tortora & grabowski 9/e 2000 jws 19-1 chapter 19 the cardiovascular system: the blood
TRANSCRIPT
19-1Tortora & Grabowski 9/e 2000 JWS
Chapter 19The Cardiovascular System: The Blood
Tortora & Grabowski 9/e 2000 JWS 19-2
• Cells of the body are serviced by 2 fluids– blood
• composed of plasma and a variety of cells• transports nutrients and wastes
– interstitial fluid• bathes the cells of the body
• Nutrients and oxygen diffuse from the blood into the interstitial fluid & then into the cells
• Wastes move in the reverse direction
• Hematology is study of blood and blood disorders
Fluids of the Body
Tortora & Grabowski 9/e 2000 JWS 19-3
Functions of Blood• Transportation
– O2, CO2, metabolic wastes, nutrients, heat & hormones
• Regulation– helps regulate pH through buffers– helps regulate body temperature
• coolant properties of water • vasodilatation of surface vessels dump heat
– helps regulate water content of cells by interactions with dissolved ions and proteins
• Protection from disease & loss of blood
Tortora & Grabowski 9/e 2000 JWS 19-4
Physical Characteristics of Blood
• Thicker (more viscous) than water and flows more slowly than water
• Temperature of 100.4 degrees F
• pH 7.4 (7.35-7.45)
• 8 % of total body weight
• Blood volume– 5 to 6 liters in average male– 4 to 5 liters in average female– hormonal negative feedback systems maintain
constant blood volume and osmotic pressure
Tortora & Grabowski 9/e 2000 JWS 19-5
Techniques of Blood Sampling
• Venipuncture– sample taken from vein with hypodermic
needle & syringe– median cubital vein (see page 717)– why not stick an artery?
• less pressure
• closer to the surface
• Finger or heel stick– common technique for diabetics to monitor
daily blood sugar– method used for infants
Tortora & Grabowski 9/e 2000 JWS 19-6
Components of Blood• Hematocrit
– 55% plasma
– 45% cells • 99% RBCs• < 1% WBCs and platelets
Tortora & Grabowski 9/e 2000 JWS 19-7
Blood Plasma• 0ver 90% water• 7% plasma proteins
• created in liver• confined to bloodstream
– albumin• maintain blood osmotic pressure
– globulins (immunoglobulins)• antibodies bind to foreign
substances called antigens• form antigen-antibody complexes
– fibrinogen• for clotting
• 2% other substances – electrolytes, nutrients, hormones, gases, waste products
Tortora & Grabowski 9/e 2000 JWS 19-8
Formed Elements of Blood• Red blood cells ( erythrocytes )• White blood cells ( leukocytes )
– granular leukocytes• neutrophils
• eosinophils
• basophils
– agranular leukocytes• lymphocytes = T cells, B cells, and natural killer cells
• monocytes
• Platelets (special cell fragments)
Tortora & Grabowski 9/e 2000 JWS 19-9
Hematocrit• Percentage of blood occupied by cells
– female normal range• 38 - 46% (average of 42%)
– male normal range• 40 - 54% (average of 46%)
• testosterone
• Anemia – not enough RBCs or not enough hemoglobin
• Polycythemia– too many RBCs (over 65%)– dehydration, tissue hypoxia, blood doping in athletes
Tortora & Grabowski 9/e 2000 JWS 19-10
Blood Doping
• Injecting previously stored RBC’s before an athletic event– more cells available to deliver oxygen to tissues
• Dangerous – increases blood viscosity
– forces heart to work harder
• Banned by Olympic committee
Tortora & Grabowski 9/e 2000 JWS 19-11
Formation of Blood Cells
• Most blood cells types need to be continually replaced– die within hours, days or weeks
– process of blood cells formation is hematopoiesis or hemopoiesis
• In the embryo– occurs in yolk sac, liver, spleen, thymus, lymph nodes
& red bone marrow
• In adult– occurs only in red marrow of flat bones like sternum,
ribs, skull & pelvis and ends of long bones
Tortora & Grabowski 9/e 2000 JWS 19-12
Hematopoiesis
Tortora & Grabowski 9/e 2000 JWS 19-13
Stages of Blood Cell Formation• Pluripotent stem cells
– .1% of red marrow cells– replenish themselves as they differentiate into either myeloid or
lymphoid stem cells
• Myeloid stem cell line of development continues:– progenitor cells(colony-forming units) no longer can divide and
are specialized to form specific cell types• example: CFU-E develops eventually into only red blood cells
– next generation is blast cells • have recognizable histological characteristics • develop within several divisions into mature cell types
• Lymphoid stem cell line of development – pre-B cells & prothymocytes finish their develop into B & T
lymphocytes in the lymphatic tissue after leaving the red marrow
Tortora & Grabowski 9/e 2000 JWS 19-14
Hemopoietic Growth Factors
• Regulate differentiation & proliferation• Erythropoietin (EPO)
– produced by the kidneys increase RBC precursors
• Thrombopoietin (TPO)– hormone from liver stimulates platelet formation
• Cytokines are local hormones of bone marrow– produced by some marrow cells to stimulate
proliferation in other marrow cells– colony-stimulating factor (CSF) & interleukin
stimulate WBC production
Tortora & Grabowski 9/e 2000 JWS 19-15
Medical Uses of Growth Factors
• Available through recombinant DNA technology– recombinant erythropoietin (EPO) very effective in
treating decreased RBC production of end-stage kidney disease
– other products given to stimulate WBC formation in cancer patients receiving chemotherapy which kills bone marrow
• granulocyte-macrophage colony-stimulating factor• granulocyte colony stimulating factor
– thrombopoietin helps prevent platelet depletion during chemotherapy
Tortora & Grabowski 9/e 2000 JWS 19-16
• Contain oxygen-carrying protein hemoglobin that gives blood its red color– 1/3 of cell’s weight is hemoglobin
• Biconcave disk 8 microns in diameter– increased surface area/volume ratio – flexible shape for narrow passages– no nucleus or other organelles
• no cell division or mitochondrial ATP formation
• Normal RBC count– male 5.4 million/drop ---- female 4.8 million/drop– new RBCs enter circulation at 2 million/second
Red Blood Cells or Erythrocytes
Tortora & Grabowski 9/e 2000 JWS 19-17
Hemoglobin
• Globin protein consisting of 4 polypeptide chains• One heme pigment attached to each polypeptide chain
– each heme contains an iron ion (Fe+2) that can combine reversibly with one oxygen molecule
Tortora & Grabowski 9/e 2000 JWS 19-18
Transport of O2, CO2 and Nitric Oxide• Each hemoglobin molecule can carry 4 oxygen
molecules from lungs to tissue cells• Hemoglobin transports 23% of total CO2 waste
from tissue cells to lungs for release– combines with amino acids in globin portion of Hb
• Hemoglobin transports nitric oxide & super nitric oxide helping to regulate BP– iron ions pick up nitric oxide (NO) & super nitric oxide
(SNO)& transport it to & from the lungs
– NO causing vasoconstriction is released in the lungs
– SNO causing vasodilation is picked up in the lungs
Tortora & Grabowski 9/e 2000 JWS 19-19
RBC Life Cycle
• RBCs live only 120 days– wear out from bending to fit through capillaries
– no repair possible due to lack of organelles
• Worn out cells removed by fixed macrophages in spleen & liver
• Breakdown products are recycled
Tortora & Grabowski 9/e 2000 JWS 19-20
Recycling of Hemoglobin Components
• In macrophages of liver or spleen – globin portion broken down into amino acids & recycled– heme portion split into iron (Fe+3) and biliverdin (green pigment)
Tortora & Grabowski 9/e 2000 JWS 19-21
Fate of Components of Heme
• Iron(Fe+3) – transported in blood attached to transferrin protein– stored in liver, muscle or spleen
• attached to ferritin or hemosiderin protein
– in bone marrow being used for hemoglobin synthesis
• Biliverdin (green) converted to bilirubin (yellow)– bilirubin secreted by liver into bile
• converted to urobilinogen then stercobilin (brown pigment in feces) by bacteria of large intestine
• if reabsorbed from intestines into blood is converted to a yellow pigment, urobilin and excreted in urine
Tortora & Grabowski 9/e 2000 JWS 19-22
Erythropoiesis: Production of RBCs
• Proerythroblast starts to produce hemoglobin• Many steps later, nucleus is ejected & a reticulocyte is
formed – orange in color with traces of visible rough ER
• Reticulocytes escape from bone marrow into the blood• In 1-2 days, they eject the remaining organelles to
become a mature RBC
Tortora & Grabowski 9/e 2000 JWS 19-23
Feedback Control of RBC Production
• Tissue hypoxia (cells not getting enough O2)– high altitude since air has less O2– anemia
• RBC production falls below RBC destruction
– circulatory problems
• Kidney response to hypoxia– release erythropoietin– speeds up development of
proerythroblasts into reticulocytes
Tortora & Grabowski 9/e 2000 JWS 19-24
Normal Reticulocyte Count
• Should be .5 to 1.5% of the circulating RBC’s
• Low count in an anemic person might indicate bone marrow problem– leukemia, nutritional deficiency or failure of red
bone marrow to respond to erythropoietin stimulation
• High count might indicate recent blood loss or successful iron therapy
Tortora & Grabowski 9/e 2000 JWS 19-25
WBC Anatomy and Types
• All WBCs (leukocytes) have a nucleus and no hemoglobin
• Granular or agranular classification based on presence of cytoplasmic granules made visible by staining– granulocytes are neutrophils, eosinophils or
basophils– agranulocytes are monocyes or lymphocytes
Tortora & Grabowski 9/e 2000 JWS 19-26
Neutrophils (Granulocyte)
• Polymorphonuclear Leukocytes or Polys• Nuclei = 2 to 5 lobes connected by thin strands
– older cells have more lobes– young cells called band cells because of horseshoe
shaped nucleus (band)
• Fine, pale lilac practically invisible granules • Diameter is 10-12 microns • 60 to 70% of circulating WBCs
Tortora & Grabowski 9/e 2000 JWS 19-27
Eosinophils (Granulocyte)
• Nucleus with 2 or 3 lobes connected by a thin strand
• Large, uniform-sized granules stain orange-red with acidic dyes– do not obscure the nucleus
• Diameter is 10 to 12 microns
• 2 to 4% of circulating WBCs
Tortora & Grabowski 9/e 2000 JWS 19-28
Basophils (Granulocyte)
• Large, dark purple, variable-sized granules stain with basic dyes– obscure the nucleus
• Irregular, s-shaped, bilobed nuclei
• Diameter is 8 to 10 microns
• Less than 1% of circulating WBCs
Tortora & Grabowski 9/e 2000 JWS 19-29
Lymphocyte (Agranulocyte)
• Dark, oval to round nucleus
• Cytoplasm sky blue in color– amount varies from rim of blue to normal amount
• Small cells 6 - 9 microns in diameter
• Large cells 10 - 14 microns in diameter– increase in number during viral infections
• 20 to 25% of circulating WBCs
Tortora & Grabowski 9/e 2000 JWS 19-30
Monocyte (Agranulocyte)• Nucleus is kidney or horse-shoe shaped
• Largest WBC in circulating blood– does not remain in blood long before migrating to the tissues
– differentiate into macrophages• fixed group found in specific tissues
– alveolar macrophages in lungs– kupffer cells in liver
• wandering group gathers at sites of infection
• Diameter is 12 - 20 microns
• Cytoplasm is a foamy blue-gray
• 3 to 8% o circulating WBCs
Tortora & Grabowski 9/e 2000 JWS 19-31
WBC Physiology• Less numerous than RBCs
– 5000 to 10,000 cells per drop of blood– 1 WBC for every 700 RBC
• Leukocytosis is a high white blood cell count– microbes, strenuous exercise, anesthesia or surgery
• Leukopenia is low white blood cell count– radiation, shock or chemotherapy
• Only 2% of total WBC population is in circulating blood at any given time– rest is in lymphatic fluid, skin, lungs, lymph nodes &
spleen
Tortora & Grabowski 9/e 2000 JWS 19-32
Emigration & Phagocytosis in WBCs• WBCs roll along endothelium,
stick to it & squeeze between cells.– adhesion molecules (selectins) help
WBCs stick to endothelium• displayed near site of injury
– molecules (integrins) found on neutrophils assist in movement through wall
• Neutrophils & macrophages phagocytize bacteria & debris– chemotaxis of both
• kinins from injury site & toxins
Tortora & Grabowski 9/e 2000 JWS 19-33
Neutrophil Function
• Fastest response of all WBC to bacteria
• Direct actions against bacteria– release lysozymes which destroy/digest bacteria– release defensin proteins that act like antibiotics &
poke holes in bacterial cell walls destroying them– release strong oxidants (bleach-like, strong chemicals )
that destroy bacteria
Tortora & Grabowski 9/e 2000 JWS 19-34
Monocyte Function
• Take longer to get to site of infection, but arrive in larger numbers
• Become wandering macrophages, once they leave the capillaries
• Destroy microbes and clean up dead tissue following an infection
Tortora & Grabowski 9/e 2000 JWS 19-35
Basophil Function
• Involved in inflammatory and allergy reactions• Leave capillaries & enter connective tissue as mast
cells• Release heparin, histamine & serotonin
– heighten the inflammatory response and account for hypersensitivity (allergic) reaction
Tortora & Grabowski 9/e 2000 JWS 19-36
Eosinophil Function
• Leave capillaries to enter tissue fluid
• Release histaminase – slows down inflammation caused by basophils
• Attack parasitic worms
• Phagocytize antibody-antigen complexes
Tortora & Grabowski 9/e 2000 JWS 19-37
Lymphocyte Functions
• B cells– destroy bacteria and their toxins– turn into plasma cells that produces antibodies
• T cells– attack viruses, fungi, transplanted organs, cancer cells
& some bacteria
• Natural killer cells– attack many different microbes & some tumor cells– destroy foreign invaders by direct attack
Tortora & Grabowski 9/e 2000 JWS 19-38
Differential WBC Count • Detection of changes in numbers of circulating
WBCs (percentages of each type)– indicates infection, poisoning, leukemia, chemotherapy,
parasites or allergy reaction
• Normal WBC counts– neutrophils 60-70% (up if bacterial infection)– lymphocyte 20-25% (up if viral infection)– monocytes 3 -- 8 % (up if fungal/viral infection)– eosinophil 2 -- 4 % (up if parasite or allergy reaction)– basophil <1% (up if allergy reaction or hypothyroid)
Tortora & Grabowski 9/e 2000 JWS 19-39
Bone Marrow Transplant• Intravenous transfer of healthy bone marrow
• Procedure– destroy sick bone marrow with radiation &
chemotherapy– donor matches surface antigens on WBC– put sample of donor marrow into patient's vein for
reseeding of bone marrow– success depends on histocompatibility of donor &
recipient
• Treatment for leukemia, sickle-cell, breast, ovarian or testicular cancer, lymphoma or aplastic anemia
Tortora & Grabowski 9/e 2000 JWS 19-40
Platelet (Thrombocyte) Anatomy
• Disc-shaped, 2 - 4 micron cell fragment with no nucleus
• Normal platelet count is 150,000-400,000/drop of blood
• Other blood cell counts– 5 million red & 5-10,000 white blood cells
Tortora & Grabowski 9/e 2000 JWS 19-41
Platelets--Life History
• Platelets form in bone marrow by following steps: – myeloid stem cells to megakaryocyte-colony
forming cells to megakaryoblast to megakaryocytes whose cell fragments form platelets
• Short life span (5 to 9 days in bloodstream)– formed in bone marrow– few days in circulating blood– aged ones removed by fixed macrophages in liver
and spleen
Tortora & Grabowski 9/e 2000 JWS 19-42
Complete Blood Count
• Screens for anemia and infection• Total RBC, WBC & platelet counts;
differential WBC; hematocrit and hemoglobin measurements
• Normal hemoglobin range– infants have 14 to 20 g/100mL of blood– adult females have 12 to 16 g/100mL of blood– adult males have 13.5 to 18g/100mL of blood
Tortora & Grabowski 9/e 2000 JWS 19-43
Hemostasis
• Stoppage of bleeding in a quick & localized fashion when blood vessels are damaged
• Prevents hemorrhage (loss of a large amount of blood)
• Methods utilized– vascular spasm– platelet plug formation– blood clotting (coagulation = formation of fibrin
threads)
Tortora & Grabowski 9/e 2000 JWS 19-44
Vascular Spasm
• Damage to blood vessel produces stimulates pain receptors
• Reflex contraction of smooth muscle of small blood vessels
• Can reduce blood loss for several hours until other mechanisms can take over
• Only for small blood vessel or arteriole
Tortora & Grabowski 9/e 2000 JWS 19-45
Platelet Plug Formation• Platelets store a lot of chemicals in granules
needed for platelet plug formation– alpha granules
• clotting factors • platelet-derived growth factor
– cause proliferation of vascular endothelial cells, smooth muscle & fibroblasts to repair damaged vessels
– dense granules• ADP, ATP, Ca+2, serotonin, fibrin-stabilizing factor, &
enzymes that produce thromboxane A2
• Steps in the process– (1) platelet adhesion (2) platelet release reaction (3)
platelet aggregation
Tortora & Grabowski 9/e 2000 JWS 19-46
Platelet Adhesion
• Platelets stick to exposed collagen underlying damaged endothelial cells in vessel wall
Tortora & Grabowski 9/e 2000 JWS 19-47
Platelet Release Reaction• Platelets activated by adhesion
• Extend projections to make contact with each other
• Release thromboxane A2 & ADP activating other platelets
• Serotonin & thromboxane A2 are vasoconstrictors decreasing blood flow through the injured vessel
Tortora & Grabowski 9/e 2000 JWS 19-48
Platelet Aggregation
• Activated platelets stick together and activate new platelets to form a mass called a platelet plug
• Plug reinforced by fibrin threads formed during clotting process
Tortora & Grabowski 9/e 2000 JWS 19-49
Blood Clotting• Blood drawn from the body thickens into a gel
– gel separates into liquid (serum) and a clot of insoluble fibers (fibrin) in which the cells are trapped
• If clotting occurs in an unbroken vessel is called a thrombosis
• Substances required for clotting are Ca+2, enzymes synthesized by liver cells and substances released by platelets or damaged tissues
• Clotting is a cascade of reactions in which each clotting factor activates the next in a fixed sequence resulting in the formation of fibrin threads– prothrombinase & Ca+2 convert prothrombin into thrombin– thrombin converts fibrinogen into fibrin threads
Tortora & Grabowski 9/e 2000 JWS 19-50
Overview of the Clotting Cascade
• Prothrombinase is formed by either the intrinsic or extrinsic pathway
• Final common pathway produces fibrin threads
Tortora & Grabowski 9/e 2000 JWS 19-51
Extrinsic Pathway
• Damaged tissues leak tissue factor (thromboplastin) into bloodstream
• Prothrombinase forms in seconds
• In the presence of Ca+2, clotting factor X combines with V to form prothrombinase
Tortora & Grabowski 9/e 2000 JWS 19-52
Intrinsic Pathway
• Activation occurs– endothelium is damaged &
platelets come in contact with collagen of blood vessel wall
– platelets damaged & release phospholipids
• Requires several minutes for reaction to occur
• Substances involved: Ca+2 and clotting factors XII, X and V
Tortora & Grabowski 9/e 2000 JWS 19-53
Final Common Pathway• Prothrombinase and Ca+2
– catalyze the conversion of prothrombin to thrombin
• Thrombin– in the presence of Ca+2 converts
soluble fibrinogen to insoluble fibrin threads
– activates fibrin stabilizing factor XIII
– positive feedback effects of thrombin• accelerates formation of prothrombinase
• activates platelets to release phospholipids
Tortora & Grabowski 9/e 2000 JWS 19-54
Clot Retraction & Blood Vessel Repair
• Clot plugs ruptured area of blood vessel
• Platelets pull on fibrin threads causing clot retraction – trapped platelets release factor
XIII stabilizing the fibrin threads
• Edges of damaged vessel are pulled together
• Fibroblasts & endothelial cells repair the blood vessel
Tortora & Grabowski 9/e 2000 JWS 19-55
Role of Vitamin K in Clotting
• Normal clotting requires adequate vitamin K– fat soluble vitamin absorbed if lipids are present– absorption slowed if bile release is insufficient
• Required for synthesis of 4 clotting factors by hepatocytes– factors II (prothrombin), VII, IX and X
• Produced by bacteria in large intestine
Tortora & Grabowski 9/e 2000 JWS 19-56
Hemostatic Control Mechanisms• Fibrinolytic system dissolves small, inappropriate clots &
clots at a site of a completed repair– fibrinolysis is dissolution of a clot
• Inactive plasminogen is incorporated into the clot– activation occurs because of factor XII and thrombin– plasminogen becomes plasmin (fibrinolysin) which digests fibrin
threads
• Clot formation remains localized– fibrin absorbs thrombin– blood disperses clotting factors– endothelial cells & WBC produce prostacyclin that opposes
thromboxane A2 (platelet adhesion & release)
• Anticoagulants present in blood & produced by mast cells
–
Tortora & Grabowski 9/e 2000 JWS 19-57
Intravascular Clotting• Thrombosis
– clot (thrombus) forming in an unbroken blood vessel• forms on rough inner lining of BV• if blood flows too slowly (stasis) allowing clotting factors to
build up locally & cause coagulation
– may dissolve spontaneously or dislodge & travel
• Embolus – clot, air bubble or fat from broken bone in the blood
• pulmonary embolus is found in lungs
• Low dose aspirin blocks synthesis of thromboxane A2 & reduces inappropriate clot formation– strokes, TIAs and myocardial infarctions
Tortora & Grabowski 9/e 2000 JWS 19-58
Anticoagulants and Thrombolytic Agents• Anticoagulants suppress or prevent blood clotting
– heparin• administered during hemodialysis and surgery
– warfarin (Coumadin)• antagonist to vitamin K so blocks synthesis of clotting factors• slower than heparin
– stored blood in blood banks treated with citrate phosphate dextrose (CPD) that removes Ca+2
• Thrombolytic agents are injected to dissolve clots– directly or indirectly activate plasminogen
– streptokinase or tissue plasminogen activator (t-PA)
Tortora & Grabowski 9/e 2000 JWS 19-59
Blood Groups and Blood Types
• RBC surfaces are marked by genetically determined glycoproteins & glycolipids – agglutinogens or isoantigens– distinguishes at least 24 different blood groups
• ABO, Rh, Lewis, Kell, Kidd and Duffy systems
Tortora & Grabowski 9/e 2000 JWS 19-60
ABO Blood Groups• Based on 2 glycolipid isoantigens called A and B found on the
surface of RBCs– display only antigen A -- blood type A– display only antigen B -- blood type B– display both antigens A & B -- blood type AB– display neither antigen -- blood type O
• Plasma contains isoantibodies or agglutinins to the A or B antigens not found in your blood– anti-A antibody reacts with antigen A– anti-B antibody reacts with antigen B
Tortora & Grabowski 9/e 2000 JWS 19-61
RH blood groups
• Antigen was discovered in blood of Rhesus monkey
• People with Rh agglutinogens on RBC surface are Rh+. Normal plasma contains no anti-Rh antibodies
• Antibodies develop only in Rh- blood type & only with exposure to the antigen– transfusion of positive blood– during a pregnancy with a positive blood type fetus
• Transfusion reaction upon 2nd exposure to the antigen results in hemolysis of the RBCs in the donated blood
Tortora & Grabowski 9/e 2000 JWS 19-62
Hemolytic Disease of Newborn
• Rh negative mom and Rh+ fetus will have mixing of blood at birth• Mom's body creates Rh antibodies unless she receives a RhoGam shot
soon after first delivery, miscarriage or abortion– RhoGam binds to loose fetal blood and removes it from body before she reacts
• In 2nd child, hemolytic disease of the newborn may develop causing hemolysis of the fetal RBCs
Tortora & Grabowski 9/e 2000 JWS 19-63
Transfusion and Transfusion Reactions
• Transfer of whole blood, cells or plasma into the bloodstream of recipient– used to treat anemia or severe blood loss
• Incompatible blood transfusions– antigen-antibody complexes form between plasma antibodies
& “foreign proteins” on donated RBC's (agglutination)
– donated RBCs become leaky (complement proteins) & burst
– loose hemoglobin causes kidney damage
• Problems caused by incompatibility between donor’s cells and recipient’s plasma
• Donor plasma is too diluted to cause problems
Tortora & Grabowski 9/e 2000 JWS 19-64
Universal Donors and Recipients
• People with type AB blood called “universal recipients” since have no antibodies in plasma– only true if cross match the blood for other
antigens
• People with type O blood cell called “universal donors” since have no antigens on their cells– theoretically can be given to anyone
Tortora & Grabowski 9/e 2000 JWS 19-65
Typing and Cross-Matching Blood• Mixing of incompatible blood causes agglutination
(visible clumping)– formation of antigen-antibody complex that sticks cells
together– not the same as blood clotting
• Typing involves testing blood with known antisera that contain antibodies A, B or Rh+
• Cross-matching is to test by mixing donor cells with recipient’s serum
• Screening is to test recipient’s serum against known RBC’s having known antigens
Tortora & Grabowski 9/e 2000 JWS 19-66
Anemia = Not Enough RBCs• Symptoms
– oxygen-carrying capacity of blood is reduced– fatigue, cold intolerance & paleness
• lack of O2 for ATP & heat production
• Types of anemia– iron-deficiency =lack of absorption or loss of iron– pernicious = lack of intrinsic factor for B12 absorption– hemorrhagic = loss of RBCs due to bleeding (ulcer)– hemolytic = defects in cell membranes cause rupture– thalassemia = hereditary deficiency of hemoglobin– aplastic = destruction of bone marrow (radiation/toxins)
Tortora & Grabowski 9/e 2000 JWS 19-67
Sickle-cell Anemia (SCA)• Genetic defect in hemoglobin molecule (Hb-S)
that changes 2 amino acids – at low very O2 levels, RBC is deformed by changes in
hemoglobin molecule within the RBC• sickle-shaped cells rupture easily = causing anemia & clots
• Found among populations in malaria belt– Mediterranean Europe, sub-Saharan Africa & Asia
• Person with only one sickle cell gene– increased resistance to malaria because RBC
membranes leak K+ & lowered levels of K+ kill the parasite infecting the red blood cells
Tortora & Grabowski 9/e 2000 JWS 19-68
Hemophilia• Inherited deficiency of clotting factors
– bleeding spontaneously or after minor trauma– subcutaneous & intramuscular hemorrhaging– nosebleeds, blood in urine, articular bleeding & pain
• Hemophilia A lacks factor VIII (males only)– most common
• Hemophilia B lacks factor IX (males only)• Hemophilia C (males & females)
– less severe because alternate clotting activator exists
• Treatment is transfusions of fresh plasma or concentrates of the missing clotting factor
Tortora & Grabowski 9/e 2000 JWS 19-69
Disseminated Intravascular Clotting
• Life threatening paradoxical presence of blood clotting and bleeding at the same time throughout the whole body– so many clotting factors are removed by
widespread clotting that too few remain to permit normal clotting
• Associated with infections, hypoxia, low blood flow rates, trauma, hypotension & hemolysis
• Clots cause ischemia and necrosis leading to multisystem organ failure
Tortora & Grabowski 9/e 2000 JWS 19-70
Leukemia
• Acute leukemia– uncontrolled production of immature leukocytes– crowding out of normal red bone marrow cells by
production of immature WBC– prevents production of RBC & platelets
• Chronic leukemia– accumulation of mature WBC in bloodstream
because they do not die– classified by type of WBC that is predominant---
monocytic, lymphocytic.